key: cord-0778241-6hvbyaju
authors: Wang, Weijian; Wang, Xiao; Zhang, Yong; Cheng, Jingliang
title: Clinical manifestation and dynamic changes of computerized tomography features of novel coronavirus pneumonia
date: 2021-06-23
journal: Asian J Surg
DOI: 10.1016/j.asjsur.2021.06.010
sha: ce92205a64c9b850c7672939f1c07e42b5b8db77
doc_id: 778241
cord_uid: 6hvbyaju

nan

The author has no conflict of Interest to declare. The clinical and CT features of 12 patients with COVID-19 confirmed by viral nucleic acid test and clinical diagnosis were retrospectively analyzed, and attention was paid to the dynamic changes of the CT images.

All 12 COVID-19 patients (eight males and four females) had fever, among whom two had high fever (12.7%), three had moderate fever (25.0%), and seven had low fever (58.3%). Seven patients (58.3%) had a history of living in Wuhan, and five patients (41.7%) had not been to Wuhan.

All patients underwent chest CT non-enhanced scanning, presenting single or multiple groundglass opacity (GGO) in one or both lungs (Figure 1 ). Patchy consolidation was found in three J o u r n a l P r e -p r o o f patients (25%), and two patients (16.7%) had air bronchogram. Scanning was performed every 2-7 days, three to four times for each patient. Data from 53 CT scans were collected. After 2-6 days of follow-up, CT revealed that 10 patients (83.3%) had an increased lesion number and an enlarged lesion scope and increased density. In some patients, the lesions had fused into large pieces, gradually involving more than one lobe of both lungs. In two patients (16.7%), CT revealed absorption and improvement of the lesions. After 6-10 days, eight patients (66.7%) showed further improvement of lung lesions, while after more than 10 days, CT showed that the original lung lesions were clearly absorbed. This result indicates that the patient's condition has entered the chronic stage.

Importantly, in CT imaging, NCP must be differentiated from other viral pneumonia, such as influenza virus, adenovirus, respiratory syncytial virus, severe acute respiratory syndrome (SARS), and Middle East respiratory syndrome (MERS) coronavirus pneumonia [4] [5] .

In conclusion, chest CT is the first choice imaging examination method for screening and diagnosing COVID-19. Although the novel coronavirus nucleic acid test is needed for the final diagnosis, the dynamic changes of CT images offer the benefit of enabling the clinical treatment effect to be evaluated.

[1] National Health Commission. Covid-19 Diagnostic Protocol (Trial 8th Edition). [EB/OL].

[2020-08-19].

J o u r n a l P r e -p r o o f

A novel coronavirus from patients with pneumonia in China

CT Imaging features of 2019 novel coronavirus (2019-nCoV)

SARS and other coronaviruses as causes of pneumonia

Figure legends: Figure 1: The patient is a 45-year-old female diagnosed with novel coronavirus pneumonia. Figure 1a: A thin and small piece of GGO in the lower lobe of the right lung on the first chest CT scan on